Prelude Therapeutics
PRLD
#9260
Rank
S$71.73 M
Marketcap
$1.30
Share price
0.57%
Change (1 day)
-69.83%
Change (1 year)

Prelude Therapeutics (PRLD) - Cash on Hand

Cash on Hand as of June 2024 : S$0.24 Billion

According to Prelude Therapeutics's latest financial reports the company has S$0.24 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Prelude Therapeutics - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.30 B13.76%
2022-12-31S$0.27 B-31.31%
2021-12-31S$0.39 B36.33%
2020-12-31S$0.28 B1034.71%
2019-12-31S$25.45 M19.47%
2018-12-31S$21.3 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.38 B 59.25%๐Ÿ‡บ๐Ÿ‡ธ USA